ACHN
Teniendo en cuenta que tienen que votarla los accionistas y que faltan meses para que se lleve a cabo yo pillaría corriendo los 6.67 que dan ahora mismo en en el pre. Edito: pero eso soy yo...
Alexion’s acquisition of Achillion is subject to the approval of Achillion shareholders and satisfaction of customary closing conditions and approval from relevant regulatory agencies, including clearance under the Hart-Scott Rodino Antitrust Improvements Act. Pending these approvals, the transaction is expected to close in the first half of 2020.
The transaction includes the potential for additional consideration in the form of non-tradeable contingent value rights (CVRs), which will be paid to Achillion shareholders if certain clinical and regulatory milestones are achieved within specified periods. These include $1.00 per share for the U.S. FDA approval of danicopan and $1.00 per share for ACH-5228 Phase 3 initiation.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
